WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027396) MEDICAMENTS BASED ON COMBINATIONS OF LACIDIPINE AND TELMISARTAN OR OF PHYSIOLOGICAL DERIVATIVES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027396    International Application No.:    PCT/EP1999/008226
Publication Date: 18.05.2000 International Filing Date: 03.11.1999
IPC:
A61K 31/44 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN (GB) (For All Designated States Except US).
BOEHRINGER INGELHEIM INTERNATIONAL GMBH [DE/DE]; Binger Strasse 173 D-55216 Ingelheim am Rhein (DE) (For All Designated States Except US).
GAVIRAGHI, Giovanni [IT/IT]; (IT) (For US Only).
QUARTAROLI, Mauro [IT/IT]; (IT) (For US Only)
Inventors: GAVIRAGHI, Giovanni; (IT).
QUARTAROLI, Mauro; (IT)
Agent: FILLER, Wendy, Anne; Glaxo Wellcome plc Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN (GB)
Priority Data:
PCT/GB98/03336 06.11.1998 GB
09/304,884 04.05.1999 US
Title (EN) MEDICAMENTS BASED ON COMBINATIONS OF LACIDIPINE AND TELMISARTAN OR OF PHYSIOLOGICAL DERIVATIVES THEREOF
(FR) MEDICAMENTS A BASE DE COMBINAISONS DE LACIDIPINE ET DE TELMISARTAN OU DE DERIVES PHYSIOLOGIQUES
Abstract: front page image
(EN)Combinations comprising diethyl (E) -4-[2-(tert-butyloxycarbonyl)vinyl]phenyl-1,4-dihydro-2,6-dimethylpyridine-3,5 dicarboxylate(lacidipine) and 4'-[[2-n-propyl-4-methyl-6-(1-methylbenziimidazol-2-yl)-benzimidazol-1-yl]-methyl]-biphenyl-2-carboxylic acid (telmisartan), pharmaceutical compositions containing said combinations and their use in the treatment of cardiovascular disorders including hypertension.
(FR)Cette invention porte sur des combinaisons comprenant du diéthyl (E)4-[2-[tert-butyloxycarbonyl)vinyl]phényl-1,4-dihydro-2,6-diméthylpyridine-3,5 dicarboxylate(lacidipine) et de l'acide 4'-[[2-n-propyl-4-méthyl-6-(1-méthylbenzimidazol-2-yl)-benzimidazol-1-yl]-méthyl]-biphényl-2-carboxylique (telmisartan). L'invention concerne également les compositions pharmaceutiques contenant lesdites combinaisons ainsi que leur utilisation dans le traitement des troubles cardiovasculaires, y compris l'hypertension.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)